Wedbush Securities Inc Novavax Inc Transaction History

Wedbush Securities Inc

$2.8 Billion
Q2 2024

A detailed history of Wedbush Securities Inc transactions in Novavax Inc stock. As of the latest transaction made, Wedbush Securities Inc holds 22,826 shares of NVAX stock, worth $209,542. This represents 0.01% of its overall portfolio holdings.

Number of Shares

22,826

Previous 11,557 97.51%

Holding current value

$209,542

Previous $55,000 425.45%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$3.89 - $20.97 $43,836 - $236,310	11,269 Added 97.51%	22,826 $289,000
Q4 2023 Feb 12, 2024	SELL	$4.8 - $7.67 $1,200 - $1,917	-250 Reduced 2.12%	11,557 $55,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $10,215 - $14,610	1,500 Added 14.55%	11,807 $85,000
Q1 2023 May 09, 2023	SELL	$5.76 - $12.48 $7,228 - $15,662	-1,255 Reduced 10.85%	10,307 $71,000
Q4 2022 Jan 31, 2023	BUY	$8.86 - $25.04 $2,480 - $7,011	280 Added 2.48%	11,562 $119,000
Q3 2022 Oct 18, 2022	BUY	$18.2 - $76.12 $5,915 - $24,739	325 Added 2.97%	11,282 $205,000
Q2 2022 Jul 21, 2022	BUY	$36.28 - $75.29 $70,383 - $146,062	1,940 Added 21.51%	10,957 $563,000
Q1 2022 Apr 19, 2022	BUY	$69.73 - $142.9 $256,676 - $526,014	3,681 Added 68.98%	9,017 $664,000
Q4 2021 Jan 13, 2022	BUY	$134.56 - $217.97 $130,119 - $210,776	967 Added 22.13%	5,336 $763,000
Q3 2021 Oct 08, 2021	BUY	$177.8 - $270.58 $114,681 - $174,524	645 Added 17.32%	4,369 $905,000
Q2 2021 Jul 27, 2021	BUY	$121.0 - $257.67 $12,100 - $25,767	100 Added 2.76%	3,724 $790,000
Q1 2021 Apr 26, 2021	SELL	$112.98 - $319.93 $83,718 - $237,068	-741 Reduced 16.98%	3,624 $657,000
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $68,976 - $122,202	876 Added 25.11%	4,365 $487,000
Q3 2020 Oct 20, 2020	SELL	$79.44 - $178.51 $95,566 - $214,747	-1,203 Reduced 25.64%	3,489 $378,000
Q2 2020 Jul 16, 2020	BUY	$13.86 - $83.61 $65,031 - $392,298	4,692 New	4,692 $391,000

Others Institutions Holding NVAX

# of Institutions

286

Shares Held

84.7M

Call Options Held

5.38M

Put Options Held

8.62M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $718M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Account

Wedbush Securities Inc Novavax Inc Transaction History